COVID-19 se asocia a un mayor riesgo de desarrollar el síndrome de Guillain-Barré, un trastorno autoinmune raro pero grave, según un nuevo estudio
Related Posts
2000 to 2016 Saw Decline in Dementia in U.S. Older Adults
WEDNESDAY, Nov. 9, 2022 (HealthDay News) -- The prevalence of dementia declined...
Decreases in Mpox Vaccination Shortfall Needed in Minorities
MONDAY, June 12, 2023 (HealthDay News) -- Achieving equitable progress in...
Jogging Past 40
I love to jog. But lately, as I trot along, sometimes my shins feel like they're...
AI Algorithm Accurately IDs Two Life-Threatening Heart Conditions
MONDAY, March 14, 2022 (HealthDay News) -- An artificial intelligence (AI) tool...